Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Retained Earnings (2018 - 2025)

Neurogene (NGNE) has disclosed Retained Earnings for 5 consecutive years, with -$327.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Retained Earnings fell 35.06% year-over-year to -$327.9 million, compared with a TTM value of -$327.9 million through Sep 2025, down 35.06%, and an annual FY2024 reading of -$262.3 million, changed N/A over the prior year.
  • Retained Earnings was -$327.9 million for Q3 2025 at Neurogene, down from -$307.0 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$204.1 million in Q1 2024 and bottomed at -$327.9 million in Q3 2025.